Literature DB >> 32489416

Use of hemoadsorption in sepsis-associated ECMO-dependent severe ARDS: A case series.

Klaus Kogelmann1, Morten Scheller1, Matthias Drüner1, Dominik Jarczak2.   

Abstract

INTRODUCTION: Acute respiratory distress syndrome in the context of severe sepsis and septic shock represents a serious clinical disorder. A recent case series in patients with septic shock and renal failure receiving hemoadsorption treatment showed rapid hemodynamic stabilization and increased survival, particularly in pneumonia patients and in those where therapy was started early. We hypothesized that patients suffering from pneumonia and refractory acute respiratory distress syndrome to the extent that they required extracorporeal membrane oxygenation support could possibly demonstrate the most pronounced benefit from the treatment.
METHODS: We assessed the association of hemoadsorption treatment with hemodynamics, ventilation, and outcome variables in a set of patients with septic shock, acute respiratory distress syndrome, need for veno-venous extracorporeal membrane oxygenation, and continuous renal replacement therapy.
RESULTS: Key observations include a significant stabilization in hemodynamics as evidenced by a marked decrease in catecholamine need, which was paralleled by a clear reduction in hyperlactatemia. Respiratory variables improved significantly. In addition, severity of illness and overall organ dysfunction showed a considerable decrease during the course of treatment. Observed mortality was approximately half as predicted by APACHE II. Treatment with CytoSorb was safe and well tolerated with no device-related adverse events. DISCUSSION: This is the first case series reporting on outcome variables associated to CytoSorb therapy in critically ill patients with septic shock, acute respiratory distress syndrome, veno-venous extracorporeal membrane oxygenation, and continuous renal replacement therapy. Based on our observations in this small case series, CytoSorb might represent a potentially promising therapy option for patients with refractory extracorporeal membrane oxygenation-dependent acute respiratory distress syndrome in the context of septic shock. © The Intensive Care Society 2018.

Entities:  

Keywords:  Acute respiratory distress syndrome; CytoSorb; continuous renal replacement therapy; extracorporeal membrane oxygenation; hemoadsorption; septic shock

Year:  2019        PMID: 32489416      PMCID: PMC7238480          DOI: 10.1177/1751143718818992

Source DB:  PubMed          Journal:  J Intensive Care Soc        ISSN: 1751-1437


  28 in total

1.  Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries.

Authors:  Giacomo Bellani; John G Laffey; Tài Pham; Eddy Fan; Laurent Brochard; Andres Esteban; Luciano Gattinoni; Frank van Haren; Anders Larsson; Daniel F McAuley; Marco Ranieri; Gordon Rubenfeld; B Taylor Thompson; Hermann Wrigge; Arthur S Slutsky; Antonio Pesenti
Journal:  JAMA       Date:  2016-02-23       Impact factor: 56.272

2.  Combination of ECMO and cytokine adsorption therapy for severe sepsis with cardiogenic shock and ARDS due to Panton-Valentine leukocidin-positive Staphylococcus aureus pneumonia and H1N1.

Authors:  N J Lees; Ajp Rosenberg; A I Hurtado-Doce; J Jones; N Marczin; M Zeriouh; A Weymann; A Sabashnikov; A R Simon; A F Popov
Journal:  J Artif Organs       Date:  2016-07-19       Impact factor: 1.731

3.  Treatment of post-cardiopulmonary bypass SIRS by hemoadsorption: a case series.

Authors:  Karl Träger; Daniel Fritzler; Guenther Fischer; Janpeter Schröder; Christian Skrabal; Andreas Liebold; Helmut Reinelt
Journal:  Int J Artif Organs       Date:  2016-04-25       Impact factor: 1.595

4.  Characteristics and outcomes in adult patients receiving mechanical ventilation: a 28-day international study.

Authors:  Andrés Esteban; Antonio Anzueto; Fernando Frutos; Inmaculada Alía; Laurent Brochard; Thomas E Stewart; Salvador Benito; Scott K Epstein; Carlos Apezteguía; Peter Nightingale; Alejandro C Arroliga; Martin J Tobin
Journal:  JAMA       Date:  2002-01-16       Impact factor: 56.272

5.  The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material.

Authors:  Niall D Ferguson; Eddy Fan; Luigi Camporota; Massimo Antonelli; Antonio Anzueto; Richard Beale; Laurent Brochard; Roy Brower; Andrés Esteban; Luciano Gattinoni; Andrew Rhodes; Arthur S Slutsky; Jean-Louis Vincent; Gordon D Rubenfeld; B Taylor Thompson; V Marco Ranieri
Journal:  Intensive Care Med       Date:  2012-08-25       Impact factor: 17.440

Review 6.  Effects of interventions on survival in acute respiratory distress syndrome: an umbrella review of 159 published randomized trials and 29 meta-analyses.

Authors:  Adriano R Tonelli; Joe Zein; Jacob Adams; John P A Ioannidis
Journal:  Intensive Care Med       Date:  2014-03-26       Impact factor: 17.440

7.  Acute respiratory distress syndrome: the Berlin Definition.

Authors:  V Marco Ranieri; Gordon D Rubenfeld; B Taylor Thompson; Niall D Ferguson; Ellen Caldwell; Eddy Fan; Luigi Camporota; Arthur S Slutsky
Journal:  JAMA       Date:  2012-06-20       Impact factor: 56.272

8.  Effect of extracorporeal cytokine removal on vascular barrier function in a septic shock patient.

Authors:  Sascha David; Kristina Thamm; Bernhard M W Schmidt; Christine S Falk; Jan T Kielstein
Journal:  J Intensive Care       Date:  2017-01-21

9.  Hemoadsorption by CytoSorb in septic patients: a case series.

Authors:  Klaus Kogelmann; Dominik Jarczak; Morten Scheller; Matthias Drüner
Journal:  Crit Care       Date:  2017-03-27       Impact factor: 9.097

10.  The effect of a novel extracorporeal cytokine hemoadsorption device on IL-6 elimination in septic patients: A randomized controlled trial.

Authors:  Dirk Schädler; Christine Pausch; Daniel Heise; Andreas Meier-Hellmann; Jörg Brederlau; Norbert Weiler; Gernot Marx; Christian Putensen; Claudia Spies; Achim Jörres; Michael Quintel; Christoph Engel; John A Kellum; Martin K Kuhlmann
Journal:  PLoS One       Date:  2017-10-30       Impact factor: 3.240

View more
  6 in total

1.  Hemoadsorption with CytoSorb in Septic Shock Reduces Catecholamine Requirements and In-Hospital Mortality: A Single-Center Retrospective 'Genetic' Matched Analysis.

Authors:  Christopher Rugg; Riko Klose; Rouven Hornung; Nicole Innerhofer; Mirjam Bachler; Stefan Schmid; Dietmar Fries; Mathias Ströhle
Journal:  Biomedicines       Date:  2020-11-26

Review 2.  Therapeutic Modulation of the Host Defense by Hemoadsorption with CytoSorb®-Basics, Indications and Perspectives-A Scoping Review.

Authors:  Thomas Köhler; Elke Schwier; Janina Praxenthaler; Carmen Kirchner; Dietrich Henzler; Claas Eickmeyer
Journal:  Int J Mol Sci       Date:  2021-11-26       Impact factor: 5.923

3.  Attenuating hyperinflammation in COVID-19: A change in paradigm?

Authors:  Zsolt Molnar; Jan Bakker
Journal:  J Crit Care       Date:  2020-07-23       Impact factor: 3.425

Review 4.  The Use of CytoSorb Therapy in Critically Ill COVID-19 Patients: Review of the Rationale and Current Clinical Experiences.

Authors:  Juan Carlos Ruiz-Rodríguez; Zsolt Molnar; Efthymios N Deliargyris; Ricard Ferrer
Journal:  Crit Care Res Pract       Date:  2021-07-17

5.  Hemoadsorption for management of patients on veno-venous ECMO support for severe COVID-19 acute respiratory distress syndrome.

Authors:  Travis C Geraci; Zachary N Kon; Nader Moazami; Stephanie H Chang; Julius Carillo; Stacey Chen; Anthony Fargnoli; Marjan Alimi; Harvey Pass; Aubrey Galloway; Deane E Smith
Journal:  J Card Surg       Date:  2021-07-04       Impact factor: 1.778

6.  Blood purification with CytoSorb in critically ill COVID-19 patients: A case series of 26 patients.

Authors:  Amir Ahmad Nassiri; Monir Sadat Hakemi; Mir Mohammad Miri; Reza Shahrami; Azadeh Ahmadi Koomleh; Tahereh Sabaghian
Journal:  Artif Organs       Date:  2021-07-06       Impact factor: 2.663

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.